Recent developments in therapy for HER2+ and HER2- Non-small cell lung cancer
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
COVID-19 is a severe acute respiratory syndrome that has blighted the world over the last year. The World Health...
In data released by GLOBOCAN 2020, stomach Cancer is the 5th biggest cancer in the world, with esophageal Cancer...
Over the last few years, there have been significant breakthroughs in the management of Type 2 diabetes (T2D). Sodium–glucose...
For several years we have approached a ‘standard of care’ (SOC) for the treatment of metastatic HER2-positive breast cancer....
Despite years of research, cancer metastasis always remains incurable and fatal. There are no approved drugs for the prevention...
Flow cytometry is a technique in which tens of thousands of cells are passed through a fluidics system, and...
Lung cancer is the number one cause of cancer-related death worldwide. Each year, about 2.2 million new cases of...
Nearly 80% of breast cancer are estrogen receptor-positive and endocrine therapy resistance occurs in approximately 30% of them.1 Researchers...
Researchers have discovered new therapeutic targets for acute myeloid leukemia (AML). A new study published in Stem Cells suggests...